scispace - formally typeset
C

Carlos Cordon-Cardo

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  620
Citations -  91832

Carlos Cordon-Cardo is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 144, co-authored 589 publications receiving 84862 citations. Previous affiliations of Carlos Cordon-Cardo include The Rogosin Institute & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma

TL;DR: Immunohistochemical studies demonstrate that ABH and Lewis antigens are differentially expressed in various cell types and developmental stages of the human gastrointestinal tract, and their expression and modulation in colorectal carcinomas is characterized.
Journal ArticleDOI

Differential requirement of mTOR in postmitotic tissues and tumorigenesis.

TL;DR: It is shown that, whereas conditional inactivation of mTOR activity has little effect in the adult mouse prostate, it markedly suppresses prostate cancer associated with loss of the tumor suppressor PTEN, and mTOR inhibitors that target its catalytic activity may be more effective in cancer therapy than those that specifically inhibit signaling mediated through mTORC1.
Journal Article

p73 Expression in Human Normal and Tumor Tissues: Loss of p73α Expression Is Associated with Tumor Progression in Bladder Cancer

TL;DR: In this paper, the expression profile of p73 in human normal tissues by immunohistochemistry (IHC) and to analyze the correlation between p73 expression and bladder cancer progression was characterized.
Journal ArticleDOI

A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.

TL;DR: The results indicate that a degree of developmental maturity can be quantitatively assigned to solid tumors, supporting the notion that transformation of a solid tumor stem cell can occur at distinct stages of maturation.